Latest Shareholder Value News

Duxton Farms has completed a A$4.55 million placement and announced a discounted Share Purchase Plan to fund its merger and development projects.

Legacy Iron Ore Limited reported solid progress in its September 2025 quarter, advancing gold production at South Laverton and pushing forward feasibility and environmental studies at the Mount Bevan magnetite project.

Culpeo Minerals reported a challenging quarter with cash outflows from operations and investing, offset by financing inflows, leaving under one quarter of funding available. The company is actively reviewing capital raising options to maintain its exploration activities.

Desane Group Holdings has declared a special 2 cent per share dividend following the sale of a key property in Lane Cove, signalling a direct return of capital to shareholders.

Aguia Resources has successfully raised approximately $4 million through a non-renounceable entitlement offer and placement of the shortfall, strengthening its capital position ahead of key project developments.

Santa Fe Minerals has completed the acquisition of the Eburnea Gold Project in Cote d’Ivoire, supported by a $1.2 million capital raise, while advancing exploration efforts in Western Australia.

C29 Metals is set to drill test two key targets at its Sampsons Tank Copper project after a strategic review, while relinquishing its Mayfield project and preparing for a capital raise.

James Hardie confirms key board changes and underscores its commitment to shareholder value amid strong integration progress with AZEK.

Karoon Energy has appointed industry veteran Carri Lockhart as its new CEO, signaling a strategic push as it prepares to operate the Baúna FPSO and expand in Brazil and the US.

Horizon Oil’s recent acquisition of Thai gas assets and a decade-long permit extension at Maari have propelled production and reserves, underpinning a strong financial quarter and sustained shareholder returns.

Paradigm Biopharmaceuticals has initiated dosing in its pivotal Phase 3 trial for knee osteoarthritis pain, backed by a strong cash position and strategic portfolio expansion. The company targets accelerated recruitment and a mid-2026 interim analysis.

L1 Group has successfully completed a $286 million institutional placement and a $19 million share sale, positioning itself for accelerated growth and strategic expansion. A follow-up share purchase plan aims to raise an additional $25 million from existing shareholders.